Shuibing Chen
Impact in
- Molecular Biology top 1%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Renal and related cancers
- Surgery top 1%
- Pancreatic function and diabetes
- Tissue Engineering and Regenerative Medicine
Papers in
-
- Pluripotent Stem Cells Research 25
- CRISPR and Genetic Engineering 15
- Surgery 33
- Pancreatic function and diabetes 26
- Co-authors
- Douglas A. Melton (4 shared papers)René Maehr (4 shared papers)Kenji Osafune (2 shared papers)Sheng Ding (6 shared papers)Danwei Huangfu (5 shared papers)Astrid Eijkelenboom (1 shared paper)Whitney E. Muhlestein (1 shared paper)Wenjun Guo (1 shared paper)
- Journals
- Cell stem cell (16 papers)Proceedings of the National Academy of Sciences (6 papers)Cell Reports (6 papers)Nature Communications (6 papers)Stem Cell Reports (5 papers)
- Partner nations
- United StatesChinaQatar
In The Last Decade
Shuibing Chen
105 papers receiving 8.4k citations
Shuibing Chen's Hit Papers
Peers
Comparison fields: 5 of 148
- Molecular Biology 5.2k
- Surgery 2.2k
- Infectious Diseases 949
- Developmental Neuroscience 181
- Aging 66
Countries citing papers authored by Shuibing Chen
This map shows the geographic impact of Shuibing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuibing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuibing Chen more than expected).
Fields of papers citing papers by Shuibing Chen
This network shows the impact of papers produced by Shuibing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuibing Chen. The network helps show where Shuibing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuibing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 Hit paper breakdown → | 2008 | 1085 |
| 2 | A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids Hit paper breakdown → | 2020 | 524 |
| 3 | 2009 | 456 | |
| 4 | Identification of SARS-CoV-2 inhibitors using lung and colonic organoids Hit paper breakdown → | 2020 | 450 |
| 5 | 2009 | 405 | |
| 6 | 2006 | 366 | |
| 7 | 2009 | 360 | |
| 8 | 2017 | 331 | |
| 9 | 2007 | 328 | |
| 10 | 2006 | 266 | |
| 11 | 2007 | 260 | |
| 12 | 2003 | 246 | |
| 13 | 2016 | 236 | |
| 14 | 2017 | 218 | |
| 15 | 2017 | 171 | |
| 16 | 2021 | 145 | |
| 17 | 2017 | 141 | |
| 18 | 2022 | 116 | |
| 19 | 2022 | 115 | |
| 20 | 2016 | 98 |
About Shuibing Chen
Shuibing Chen is a scholar working on Molecular Biology, Surgery, Infectious Diseases, Genetics and Immunology, having authored 108 papers that have together received 8.6k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (26 papers), Pluripotent Stem Cells Research (25 papers), CRISPR and Genetic Engineering (15 papers), SARS-CoV-2 and COVID-19 Research (12 papers), 3D Printing in Biomedical Research (10 papers), COVID-19 Clinical Research Studies (8 papers), Genetics and Neurodevelopmental Disorders (8 papers) and Diabetes and associated disorders (7 papers). The work is most often cited by research in Molecular Biology (5.2k citations), Surgery (2.2k citations), Infectious Diseases (949 citations), Developmental Neuroscience (181 citations) and Aging (66 citations). Shuibing Chen has collaborated with scholars based in United States, China and Qatar. Frequent co-authors include Douglas A. Melton, René Maehr, Kenji Osafune, Sheng Ding, Danwei Huangfu, Astrid Eijkelenboom, Whitney E. Muhlestein, Wenjun Guo, Todd Evans and Qisheng Zhang. Their work appears in journals such as Cell stem cell, Proceedings of the National Academy of Sciences, Cell Reports, Nature Communications and Stem Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.